<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00762554</url>
  </required_header>
  <id_info>
    <org_study_id>goodman-1</org_study_id>
    <nct_id>NCT00762554</nct_id>
  </id_info>
  <brief_title>Depodur vs Fentanyl Infusion for Post-C/S Analgesia</brief_title>
  <official_title>A Comparison of Single Dose Depodur With Fentanyl Infusion for Post-Cesarean Section Analgesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Goodman, Evan, M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Goodman, Evan, M.D.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epidurally administered Depodur provides equal or superior analgesia as an epidural infusion
      of fentanyl for the first 48 hours after a cesarean section.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2008</start_date>
  <completion_date type="Anticipated">June 2009</completion_date>
  <primary_completion_date type="Anticipated">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Degree of analgesia (measured on a 10-point scale)</measure>
    <time_frame>48 hours post-operatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of minor side effects, such as pruritis or nausea.</measure>
    <time_frame>48 hours postoperatively</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Epidural Depodur after epidural lidocaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Epidural Depodur after spinal bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Epidural fentanyl infusion after epidural lidocaine or spinal bupivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Depodur</intervention_name>
    <description>Depodur 10mg given epidurally at end of cesarean section.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Depodur</intervention_name>
    <description>Depodur 10mg given epidurally at end of cesarean section after patient received spinal bupivacaine at the beginning of the case.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Epidural fentanyl infusion started after epidural lidocaine or spinal bupivacaine used for the cesarean section.</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy pregnant women (ASA I or II) who are scheduled for an elective cesarean
             section

          -  Patient appropriate for regional anesthesia

          -  Patient agrees to receive regional anesthesia

          -  Patient willing to have an epidural infusion of medication for two days
             postoperatively

        Exclusion Criteria:

          -  Morbid obesity

          -  History of sleep apnea

          -  Allergy to opioids medications

          -  History of opioids use during week prior to procedure

          -  Emergency cesarean section

          -  Significant surgical complications

          -  Contraindication or refusal to have regional anesthesia

          -  Age less than 18
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Evan Goodman, MD</last_name>
      <phone>216-844-5300</phone>
      <email>evan.goodman@uhhospitals.org</email>
    </contact>
    <contact_backup>
      <last_name>Susan Dumas, MD</last_name>
      <phone>2168447330</phone>
      <email>susan.dumas@uhhospitals.org</email>
    </contact_backup>
    <investigator>
      <last_name>Evan Goodman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Carvalho B, Riley E, Cohen SE, Gambling D, Palmer C, Huffnagle HJ, Polley L, Muir H, Segal S, Lihou C, Manvelian G; DepoSur Study Group. Single-dose, sustained-release epidural morphine in the management of postoperative pain after elective cesarean delivery: results of a multicenter randomized controlled study. Anesth Analg. 2005 Apr;100(4):1150-8.</citation>
    <PMID>15781537</PMID>
  </reference>
  <reference>
    <citation>Carvalho B, Roland LM, Chu LF, Campitelli VA 3rd, Riley ET. Single-dose, extended-release epidural morphine (DepoDur) compared to conventional epidural morphine for post-cesarean pain. Anesth Analg. 2007 Jul;105(1):176-83.</citation>
    <PMID>17578973</PMID>
  </reference>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 29, 2008</study_first_submitted>
  <study_first_submitted_qc>September 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2008</study_first_posted>
  <last_update_submitted>September 29, 2008</last_update_submitted>
  <last_update_submitted_qc>September 29, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 30, 2008</last_update_posted>
  <responsible_party>
    <name_title>Evan Goodman, MD</name_title>
    <organization>University Hospitals Case Medical Center</organization>
  </responsible_party>
  <keyword>analgesia</keyword>
  <keyword>cesarean section</keyword>
  <keyword>fentanyl</keyword>
  <keyword>Depodur</keyword>
  <keyword>Post-cesarean section analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Agnosia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

